Published in J Clin Microbiol on September 01, 2005
Development and application of a broadly sensitive dried-blood-spot-based genotyping assay for global surveillance of HIV-1 drug resistance. J Clin Microbiol (2010) 1.52
Multicenter performance evaluation of a new TaqMan PCR assay for monitoring human immunodeficiency virus RNA load. J Clin Microbiol (2006) 1.29
High failure rate of the ViroSeq HIV-1 genotyping system for drug resistance testing in Cameroon, a country with broad HIV-1 genetic diversity. J Clin Microbiol (2011) 0.99
Viral Genetic Diversity and Polymorphisms in a Cohort of HIV-1-Infected Patients Eligible for Initiation of Antiretroviral Therapy in Abuja, Nigeria. AIDS Res Hum Retroviruses (2015) 0.81
Clinical utility of genotypic resistance tests for HIV-1-infected patients with low-level virological failure. J Clin Microbiol (2010) 0.75
Pitfalls of antiretroviral drug resistance genotyping of HIV-1 Group M and Group N from Cameroon by sequenced-based assays. Niger Med J (2016) 0.75
Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel. JAMA (2000) 7.81
HIV-1 nomenclature proposal. Science (2000) 6.61
Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial. Lancet (1999) 4.68
Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database. Nucleic Acids Res (1999) 3.44
Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J Acquir Immune Defic Syndr (2002) 3.40
HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed. Ann Intern Med (1999) 2.36
Accuracy of the TRUGENE HIV-1 genotyping kit. J Clin Microbiol (2003) 2.32
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Med (2003) 1.94
Drug resistance in non-subtype B HIV-1. J Clin Virol (2004) 1.56
Human immunodeficiency virus type 1 drug resistance testing: a comparison of three sequence-based methods. J Clin Microbiol (2001) 1.49
Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study. AIDS (1999) 1.44
Ethnic differences in stage of presentation of adults newly diagnosed with HIV-1 infection in south London. HIV Med (2005) 1.16
Performance characteristics of human immunodeficiency virus type 1 (HIV-1) genotyping systems in sequence-based analysis of subtypes other than HIV-1 subtype B. J Clin Microbiol (2003) 1.08
Performance of two commercially available sequence-based HIV-1 genotyping systems for the detection of drug resistance against HIV type 1 group M subtypes. J Med Virol (2003) 1.06
Clinical implications of identifying non-B subtypes of human immunodeficiency virus type 1 infection. Clin Infect Dis (2000) 0.96
HIV seroprevalence among women attending antenatal clinics in London. Lancet (1992) 4.46
Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission. HIV Med (2001) 2.33
In-vitro detection of human rotaviruses. Lancet (1975) 2.28
Viremia, virus excretion, and antibody responses after challenge in volunteers with low levels of antibody to rubella virus. J Infect Dis (1983) 2.07
Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men. Neurology (2009) 2.00
New mutations associated with resistance not detected following zidovudine monotherapy in pregnancy when used in accordance with British HIV Association guidelines. HIV Med (2008) 1.99
Asymptomatic endemic rotavirus infections in the newborn. Lancet (1978) 1.93
Letter: Rotavirus infections in a maternity unit. Lancet (1975) 1.92
The effect of trypsin on the growth of rotavirus. J Gen Virol (1978) 1.86
Rotavirus infections in a maternity unit. Arch Dis Child (1976) 1.71
Cardiovascular risk evaluation and antiretroviral therapy effects in an HIV cohort: implications for clinical management: the CREATE 1 study. Int J Clin Pract (2010) 1.68
Rubella vaccination: persistence of antibodies for up to 16 years. Br Med J (Clin Res Ed) (1982) 1.66
Clinical evaluation of the turkey-erythrocyte passive-haemagglutination test for hepatitis-B surface antigen. Lancet (1974) 1.59
Rubella immunity by four different techniques: results of challenge studies. J Med Virol (1980) 1.58
Development and degeneration of retina in rds mutant mice: light microscopy. J Comp Neurol (1980) 1.53
The ilvB locus of Escherichia coli K-12 is an operon encoding both subunits of acetohydroxyacid synthase I. Nucleic Acids Res (1985) 1.49
Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut (2003) 1.48
PCR for detection of rubella virus RNA in clinical samples. J Clin Microbiol (1995) 1.47
bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc Natl Acad Sci U S A (1995) 1.40
Paediatric gastroenteritis in the eastern Malaysian state of Sarawak: an epidemiological and clinical study. Trans R Soc Trop Med Hyg (1988) 1.39
Veterinary nursing examinations. Vet Rec (1994) 1.38
Use of dried whole blood spots for quantification of HIV-1 RNA. AIDS (1999) 1.33
British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008. HIV Med (2008) 1.33
Persistence of specific IgM and low avidity specific IgG1 following primary rubella. J Virol Methods (1992) 1.32
Retrospective study of HIV, hepatitis B, and HTLV-I infection at a London antenatal clinic. Lancet (1990) 1.30
Persistence of rubella antibody 8-18 years after vaccination. Br Med J (Clin Res Ed) (1984) 1.30
HIV screening in pregnancy: UK lags. Lancet (1994) 1.20
Cord blood and breast-milk antibodies in neonatal rotavirus infection. Br Med J (1980) 1.19
Development and persistence of class-specific antibodies in the serum and nasopharyngeal washings of rubella vaccinees. J Infect Dis (1985) 1.18
Rubella vaccines. Lancet (1979) 1.10
Persistence of rubella antibodies after vaccination: detection after experimental challenge. Rev Infect Dis (1985) 1.08
Chronic enteric virus infection in two T-cell immunodeficient children. J Med Virol (1988) 1.07
UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure (2011). Int J STD AIDS (2011) 1.07
Isolation of a new foamy retrovirus from orangutans. J Virol (1994) 1.06
Antiretroviral therapy for HIV-2 infected patients. J Infect (2001) 1.04
Randomized controlled trial of supervised patient self-testing of warfarin therapy using an internet-based expert system. J Thromb Haemost (2009) 1.04
Rubella serology by solid-phase radioimmunoassay: its potential for screening programmes. Clin Exp Immunol (1978) 1.03
Evidence for horizontal and not vertical transmission of human herpesvirus 8 in children born to human immunodeficiency virus-infected mothers. Pediatr Infect Dis J (1999) 1.02
Radiation treatment of advanced or recurrent granulosa cell tumor of the ovary. Gynecol Oncol (1999) 1.02
Transmission of RA27/3 rubella vaccine strain to products of conception. Lancet (1981) 1.01
Use of PCR for prenatal and postnatal diagnosis of congenital rubella. J Clin Microbiol (1995) 1.01
Hepatitis C transmission -- where are we now? Int J STD AIDS (2006) 0.99
Slow maturation of IgG1 avidity and persistence of specific IgM in congenital rubella: implications for diagnosis and immunopathology. J Med Virol (1993) 0.98
Neonatal rotavirus infection: role of lacteal neutralising alpha1-anti-trypsin and nonimmunoglobulin antiviral activity in protection. J Med Virol (1982) 0.98
Renal medullary carcinoma: sonographic, computed tomography, magnetic resonance and angiographic findings. Eur J Radiol (2000) 0.98
The reliability of point-of-care prothrombin time testing. A comparison of CoaguChek S and XS INR measurements with hospital laboratory monitoring. Int J Lab Hematol (2008) 0.97
British HIV Association guidelines for the management of coinfection with HIV-1 and hepatitis B or C virus 2010. HIV Med (2010) 0.97
Laminin in lung development: effects of anti-laminin antibody in murine lung morphogenesis. Dev Biol (1990) 0.97
Potential risk of cross-infection during peripheral-venous access by contamination of tourniquets. Lancet (2000) 0.97
BK antibody and virus-specific IgM responses in renal transplant recipients, patients with malignant disease, and healthy people. Br Med J (1977) 0.96
How well do low levels of rubella antibody protect? Lancet (1981) 0.96
False positive rotazyme tests on faecal samples from babies. Lancet (1983) 0.94
Rubella vaccination: persistence of antibodies for 10-21 years. Lancet (1988) 0.94
Insulin resistance and HIV infection: a review. Int J Clin Pract (2007) 0.94
Multicenter study of human immunodeficiency virus-related germ cell tumors. J Clin Oncol (2003) 0.93
Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV. HIV Med (2005) 0.93
Systemic lymphoproliferative responses to rotavirus. J Med Virol (1988) 0.93
Automated rubella antibody screening:a cautionary tale. J Med Microbiol (1999) 0.93
An altered intron inhibits synthesis of the acetylcholine receptor alpha-subunit in the paralyzed zebrafish mutant nic1. Genetics (1998) 0.92
Rotavirus gastro-enteritis in northern Nigeria. Trans R Soc Trop Med Hyg (1979) 0.91
Effects of reduced left ventricular mass on chamber architecture, load, and function: a study of anorexia nervosa. Circulation (1985) 0.91
Multicentric Castleman's disease in a patient with HIV. Int J STD AIDS (2006) 0.91
Human herpesvirus 8: seroepidemiology among women and detection in the genital tract of seropositive women. J Infect Dis (1999) 0.90
Laparoscopic reduction of an ileoileal intussusception and resection of an inverted Meckel's diverticulum in an adult. Surg Endosc (2003) 0.89
Munchausen's syndrome by proxy: a warning for health professionals. Br Med J (Clin Res Ed) (1986) 0.89
Outcome of patients with HIV-related germ cell tumours: a case-control study. Br J Cancer (2004) 0.87
Rubella virus strains show no major antigenic differences. Intervirology (1992) 0.87
Maternal viral load, CD4 cell count and vertical transmission of HIV-1. J Med Virol (1998) 0.87
Virus-specific and autoreactive T cell lines isolated from cerebrospinal fluid of a patient with chronic rubella panencephalitis. J Neuroimmunol (1989) 0.86
Women's knowledge and attitudes, and the acceptability of voluntary antenatal HIV testing. Br J Obstet Gynaecol (1998) 0.86
Prevalence of antiretroviral resistance in a South London cohort of treatment-naive HIV-1-infected patients. AIDS (2001) 0.85
Lipoxygenase inhibitors block PDGF-induced mitogenesis: a MAPK-independent mechanism that blocks fos and egr. Am J Physiol (1995) 0.84
Enhancement of human rotavirus infectivity in a monkey kidney cell line by human expressed breast milk. J Med Virol (1982) 0.84
Infection by fastidious enteric adenoviruses in childhood. Lancet (1981) 0.84
Syphilis causing hearing loss. Int J STD AIDS (2008) 0.84
Rotaviruses and the respiratory tract. Br Med J (1979) 0.84
An investigation of the role of Fusarium moniliforme in duodenitis/proximal jejunitis of horses. Vet Hum Toxicol (1995) 0.84
Rotaviral infections in human neonates. J Am Vet Med Assoc (1978) 0.84
Characterization of the three Arabidopsis thaliana RAD21 cohesins reveals differential responses to ionizing radiation. J Exp Bot (2006) 0.83
Studies on human lacteal rotavirus antibodies by immune electron microscopy. J Med Virol (1983) 0.83
HIV-2 in pregnancy: to treat or not to treat? Int J STD AIDS (1998) 0.83
Utilization of HIV point-of-care testing clinics in general practice and genitourinary medicine services in south-east London. Int J STD AIDS (2009) 0.82
Sequential rotavirus diarrhoea caused by virus of same subgroup. Lancet (1981) 0.82
Calvarial syphilis in an HIV-positive man. Int J STD AIDS (2012) 0.82
Physical breaks in the placental trophoblastic surface: significance in vertical transmission of HIV. AIDS (1996) 0.82
Managing oral anticoagulation therapy: improving clinical outcomes. A review. J Clin Pharm Ther (2008) 0.81
Bronchial smooth muscle hypoplasia in mouse embryonic lungs exposed to a laminin beta1 chain antisense oligonucleotide. Mech Dev (1999) 0.81
Post-exposure HIV prophylaxis following sexual exposure: a retrospective audit against recent draft BASHH guidance. Sex Transm Infect (2006) 0.81
Successful lung transplant in a child with cystic fibrosis and persistent Blastobotrys rhaffinosifermentans infection. Pediatr Transplant (2014) 0.81
Development of a lymphocyte transformation assay for rotavirus in whole blood and breast milk. J Med Virol (1988) 0.81
HIV clearance in an infant? Nature (1995) 0.80
The relationships between ethnicity, sex, risk group, and virus load in human immunodeficiency virus type 1 antiretroviral-naive patients. J Infect Dis (2001) 0.80
Expression of glycine receptors in rat sensory neurons vs. HEK293 cells yields different functional properties. Neurosci Lett (2001) 0.79
Absent hematuria and expensive computerized tomography: case characteristics of emergency urolithiasis. J Urol (2001) 0.79